Cargando…

Identification of high protein kinase CK2α in HPV(+) oropharyngeal squamous cell carcinoma and correlation with clinical outcomes

BACKGROUND: Oropharyngeal squamous cell carcinoma (OPSCC) incidence is rising worldwide, especially human papillomavirus (HPV)-associated disease. Historically, high levels of protein kinase CK2 were linked with poor outcomes in head and neck squamous cell carcinoma (HNSCC), without consideration of...

Descripción completa

Detalles Bibliográficos
Autores principales:	Trembley, Janeen H., Li, Bin, Kren, Betsy T., Peltola, Justin, Manivel, Juan, Meyyappan, Devi, Gravely, Amy, Klein, Mark, Ahmed, Khalil, Caicedo-Granados, Emiro
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	PeerJ Inc. 2021
Materias:	Cell Biology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8675248/ https://www.ncbi.nlm.nih.gov/pubmed/34993017 http://dx.doi.org/10.7717/peerj.12519

Ejemplares similares

CX-4945 and siRNA-Mediated Knockdown of CK2 Improves Cisplatin Response in HPV(+) and HPV(−) HNSCC Cell Lines
por: Trembley, Janeen H., et al.
Publicado: (2021)

Protein kinase CK2 – diverse roles in cancer cell biology and therapeutic promise
por: Trembley, Janeen H., et al.
Publicado: (2022)

CK2 Molecular Targeting—Tumor Cell-Specific Delivery of RNAi in Various Models of Cancer
por: Trembley, Janeen H., et al.
Publicado: (2017)

CK2 Pro-Survival Role in Prostate Cancer Is Mediated via Maintenance and Promotion of Androgen Receptor and NFκB p65 Expression
por: Trembley, Janeen H., et al.
Publicado: (2019)

Tenfibgen Ligand Nanoencapsulation Delivers Bi-Functional Anti-CK2 RNAi Oligomer to Key Sites for Prostate Cancer Targeting Using Human Xenograft Tumors in Mice
por: Trembley, Janeen H., et al.
Publicado: (2014)

Preclinical evaluation of cyclin dependent kinase 11 and casein kinase 2 survival kinases as RNA interference targets for triple negative breast cancer therapy
por: Kren, Betsy T, et al.
Publicado: (2015)

CK2 targeted RNAi therapeutic delivered via malignant cell-directed tenfibgen nanocapsule: dose and molecular mechanisms of response in xenograft prostate tumors
por: Ahmed, Khalil, et al.
Publicado: (2016)

CDK11 Loss Induces Cell Cycle Dysfunction and Death of BRAF and NRAS Melanoma Cells
por: Ahmed, Rehana L., et al.
Publicado: (2019)

HPV-Related Oropharyngeal Cancer and Biomarkers Based on Epigenetics and Microbiome Profile
por: Gougousis, Spyridon, et al.
Publicado: (2021)

Differences in T-cell infiltrates and survival between HPV+ and HPV- oropharyngeal squamous cell carcinoma
por: Matlung, Sanne Evelien, et al.
Publicado: (2016)

Oral health in HPV-positive and HPV-negative patients with oropharyngeal squamous cell carcinoma
por: Kanzow, Philipp, et al.
Publicado: (2023)

Clinical features of oral and oropharyngeal squamous cell carcinoma HPV related
por: Azevedo, Pedro Leite, et al.
Publicado: (2014)

HPV Status and second primary tumours in Oropharyngeal Squamous Cell Carcinoma
por: Xu, Caroline C, et al.
Publicado: (2013)

Targeted Therapy in Oropharyngeal Squamous Cell Carcinoma: The Implications of HPV for Therapy
por: Hay, Ashley, et al.
Publicado: (2015)

HPV-driven oropharyngeal squamous cell cancer in Croatia — Demography and survival
por: Božinović, Ksenija, et al.
Publicado: (2019)

Impact of HPV Infection on the Immune System in Oropharyngeal and Non-Oropharyngeal Squamous Cell Carcinoma: A Systematic Review
por: Lechien, Jerome R., et al.
Publicado: (2019)

Differential Activation of ERK Signaling in HPV-Related Oropharyngeal Squamous Cell Carcinoma
por: Rong, Chao, et al.
Publicado: (2019)

Sex-Related Differences in Outcomes for Oropharyngeal Squamous Cell Carcinoma by HPV Status
por: Kao, Derek D., et al.
Publicado: (2022)

Progressive Increase Trend in HPV-Related Oropharyngeal Squamous Cell Carcinoma in Brazil
por: Pires, Rafael Cardoso, et al.
Publicado: (2021)

HPV Prevalence and Predictive Biomarkers for Oropharyngeal Squamous Cell Carcinoma in Mexican Patients
por: Reyes-Hernández, Diego Octavio, et al.
Publicado: (2022)

Editorial: Considerations in the surgical management of HPV-positive oropharyngeal squamous cell carcinoma
por: Mallen-St Clair, Jon, et al.
Publicado: (2023)

Impact of HPV in Oropharyngeal Cancer
por: Marklund, Linda, et al.
Publicado: (2011)

CK1δ in lymphoma: gene expression and mutation analyses and validation of CK1δ kinase activity for therapeutic application
por: Winkler, B. Sophia, et al.
Publicado: (2015)

Whole genome sequencing reveals complexity in both HPV sequences present and HPV integrations in HPV-positive oropharyngeal squamous cell carcinomas
por: Gao, Ge, et al.
Publicado: (2019)

Validation of a novel diagnostic standard in HPV-positive oropharyngeal squamous cell carcinoma
por: Schache, A G, et al.
Publicado: (2013)

Epithelial to mesenchymal transition and HPV infection in squamous cell oropharyngeal carcinomas: the papillophar study
por: Lefevre, Marine, et al.
Publicado: (2017)

Metastatic model of HPV+ oropharyngeal squamous cell carcinoma demonstrates heterogeneity in tumor metastasis
por: Vermeer, Daniel W., et al.
Publicado: (2016)

Clinico-pathological features of oropharyngeal squamous cell carcinomas in Malaysia with reference to HPV infection
por: Yap, Lee Fah, et al.
Publicado: (2018)

A systematic review of the HPV‐attributable fraction of oropharyngeal squamous cell carcinomas in Germany
por: Reuschenbach, Miriam, et al.
Publicado: (2019)

Childhood tonsillectomy alters the primary distribution of HPV‐related oropharyngeal squamous cell carcinoma
por: Altenhofen, Brannon, et al.
Publicado: (2020)

The role of the innate and adaptive immune response in HPV‐associated oropharyngeal squamous cell carcinoma
por: Subbarayan, Rahul Sridhar, et al.
Publicado: (2019)

High-risk HPV infection-associated hypermethylated genes in oropharyngeal squamous cell carcinomas
por: Inokawa, Yoshikuni, et al.
Publicado: (2022)

Correlation of immune makers with HPV 16 infections and the prognosis in oropharyngeal squamous cell carcinoma
por: Zhu, Yingying, et al.
Publicado: (2023)

Sex differences in patients with high risk HPV-associated and HPV negative oropharyngeal and oral cavity squamous cell carcinomas
por: Li, Hong, et al.
Publicado: (2018)

Sensitive HPV detection in oropharyngeal cancers
por: Winder, David M, et al.
Publicado: (2009)

The immune response in HPV(+) oropharyngeal cancer
por: King, Emma V, et al.
Publicado: (2014)

Immunotherapy in HPV-Related Oropharyngeal Cancers
por: Roof, Logan, et al.
Publicado: (2023)

HPV-mediated oropharyngeal carcinogenesis: An overview
por: Patil†, Shankargouda
Publicado: (2022)

HPV+ Oropharyngeal Cancer in Waldenström Macroglobulinemia
por: Raslan, Shahm, et al.
Publicado: (2023)

Human papillomavirus-mediated carcinogenesis and HPV-associated oral and oropharyngeal squamous cell carcinoma. Part 2: Human papillomavirus associated oral and oropharyngeal squamous cell carcinoma
por: Feller, Liviu, et al.
Publicado: (2010)

Cannot write session to /tmp/vufind_sessions/sess_nubrhd6lqdkukdr8nqn0cnp9mf